Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). Minor beta-thalassemia (MBT) is a common genetic disorder in the Mediterranean countries with a reported genetic distribution frequency as high as 5-10 % of the normal population in some countries such as Iran. MBT proposed to increase the risk of developing autoimmune disease.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Multiple Sclerosis and Related Disorders
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2019 Published by Elsevier Inc.